XENE Operating Cash Flow (Statement)
Xenon Pharmaceuticals Inc · Operating Cash Flow (Statement)
XENE Operating Cash Flow (Statement)
Latest reported-$95.39Mperiod ending
XENE Quarterly Cash from Operations ($19.71M → -$95.39M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
XENE operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -95,390,000 | |
| -88,897,000 | |
| -81,481,000 | |
| -71,752,000 | |
| -64,233,000 | |
| -61,652,000 | |
| -54,385,000 | |
| -49,665,000 | |
| -32,679,000 | |
| -46,187,000 | |
| -35,465,000 | |
| -42,230,000 | |
| -33,221,000 | |
| -34,411,000 | |
| -32,732,000 | |
| -30,402,000 | |
| -16,868,000 | |
| -18,428,000 | |
| -20,710,000 | |
| -15,007,000 | |
| -13,077,000 | |
| -20,708,000 | |
| -13,114,000 | |
| -11,974,376 | |
| -10,441,221 | |
| -13,067,000 | |
| 19,735,000 | |
| -7,067,000 | |
| -8,633,000 | |
| -8,667,000 | |
| -7,242,000 | |
| -13,725,000 | |
| -5,538,000 | |
| -8,219,000 | |
| -6,838,000 | |
| -8,626,000 | |
| -6,802,000 | |
| -6,460,000 | |
| -4,670,000 | |
| -4,524,000 | |
| -5,429,000 | |
| -4,944,000 | |
| -5,247,000 | |
| -4,885,000 | |
| -2,424,000 | |
| -5,547,000 | |
| -2,951,000 | |
| 6,284,000 | |
| -2,225,000 | |
| -842,000 | |
| -2,686,000 | |
| 4,978,000 | |
| -2,807,000 | |
| -2,807,000 | |
| 19,713,500 | |
| 19,713,500 |